Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
This article, published in The Journal of Infectious Diseases, discusses a study examining invasive pneumococcal disease (IPD) cases from 1998 to 2007 from eight sites across the United States to assess the impact of 7-valent pneumococcal conjugate vaccine (PCV-7) introduction. The study finds that seven years after the introduction of PCV-7, an estimated 211,000 fewer cases and 13,000 fewer deaths have occurred. The authors also conclude that although IPD rates caused by serotype 19A and non-PCV7 types have risen, these rates remain low relative to decreases in PCV7-type IPD.
Author(s): Pilishvili T, Lexau C, Farley MM, et al.
Visit web page (English)
(Located at www.journals.uchicago.edu)
Citation: Pilishvili T, Lexau C, Farley MM, et al. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine. Journal of Infectious Diseases. 2010;201(1):32-41.